Immunology and Microbiology
Adaptive Immune System
10%
Antineoplastic Activity
14%
Autotransplantation
10%
B Cell
16%
Bone Marrow Transplantation
51%
Cancer Immunotherapy
31%
CD25
13%
CD3 Antigen
17%
CD4
23%
CD8
15%
Cell Death
11%
Cell Line
10%
Cell Lysate
55%
Cell Transplantation
42%
Conditioning
33%
Cyclophosphamide
48%
Cytokine
14%
Cytotoxic T Cell
15%
Cytotoxic T-Cell
23%
Cytotoxicity
11%
Dendritic Cell
80%
Engraftment
10%
Graft-Versus-Host Disease
43%
Granulocyte Macrophage Colony-Stimulating Factor
15%
Hematopoietic Cell
43%
Immune Response
18%
Immune System
13%
Immunotherapy
12%
interferon
10%
Interleukin 2
47%
Low Drug Dose
11%
Lymphocyte
29%
Mouse
55%
Myeloid
22%
Myeloid-Derived Suppressor Cell
26%
Natural Killer Cell
27%
Peripheral Blood Mononuclear Cell
14%
Regulatory T Cell
30%
Signal Transduction
10%
Splenocyte
13%
Syngenic
13%
Systemic Immunity
15%
T Cell
100%
T Cell Receptor
11%
T-Helper Cell
15%
Transplant Procedure
48%
Tumor Antigen
14%
Tumor Cell
39%
Vaccination Policy
34%
Vaccine Efficacy
27%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
24%
Acute Myeloid Leukemia
10%
Adjuvant Therapy
7%
Alternative Donor
10%
Aplastic Anemia
10%
Bendamustine
32%
Bone Marrow Transplantation
35%
Busulfan
6%
Cancer Immunotherapy
6%
Cancer in Young Adults
15%
Cardiorespiratory
6%
Cell Line
6%
Cell Therapy
8%
Cell Transplantation
31%
Chaperone
10%
Chimeric Antigen Receptor T-Cell
9%
Chronic Myelogenous Leukemia
8%
Conditioning
18%
Cyclophosphamide
23%
Cytotoxic T-Cell
7%
Dendritic Cell
20%
Disease
9%
Exercise
8%
Fludarabine
8%
Graft Versus Host Reaction
24%
Graft Versus Leukemia Effect
16%
Hematologic Malignancy
18%
Hematopoietic Stem Cell
33%
Immune System
7%
Immunotherapy
17%
In Vitro
17%
Infusion
12%
Interleukin 2
10%
Leukemia
12%
Lymphocyte
18%
Malignant Neoplasm
11%
Melphalan
6%
Myelodysplastic Syndrome
7%
Myeloid Malignancy
10%
Neoplasm
32%
Pediatrics
52%
Peripheral Blood Mononuclear Cell
11%
Quality of Life
10%
Recurrence Free Survival
9%
Signal Transduction
6%
T Cell
35%
T Helper 1 Cell
10%
T-Cell Response
11%
Transplantation
30%
Whole Body Radiation
17%
Keyphrases
Acute Lymphoblastic Leukemia
8%
Acute Myeloid Leukemia
7%
Allogeneic
7%
Allogeneic Bone Marrow Transplantation
10%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
12%
Anti-CD3
6%
Antigen-presenting Cells
10%
Apoptotic Cells
7%
Apoptotic Tumor Cells
10%
B7-1
12%
Bendamustine
20%
Bone Marrow Transplantation
7%
CD4+CD25+Foxp3+
6%
CD8+ T
7%
Chaperone Proteins
6%
Chaperone-rich Cell Lysate
38%
Cyclophosphamide
8%
Cytotoxic T Lymphocytes
7%
Dendritic Cells
19%
Graft-versus-host Disease (GvHD)
13%
Graft-versus-leukemia Effect
10%
Group-based
10%
Haploidentical Transplantation
10%
Hemoglobinopathies
10%
In Cancer
6%
Interleukin-2
21%
Killing Activity
6%
Leukemia
15%
Leukemia Cells
6%
Lymphocytes
11%
Memory T Cells
6%
Myeloid-derived Suppressor Cells
15%
Natural Killer Cells
8%
Pediatric
10%
Peripheral Blood Mononuclear Cells
6%
Post-transplantation Cyclophosphamide (PTCy)
12%
Signaling Pathway
6%
Splenocytes
6%
Systemic Immunity
10%
T Cells
18%
T-cell Replete
6%
Total Body Irradiation
16%
Treg
6%
Tumor
22%
Tumor Antigen
10%
Tumor Cell Lysate
10%
Tumor Cells
7%
Tumor Immunity
24%
Vaccination
7%
Young Adult Cancer Survivors
15%
